Stock Screener App

Frei -

Installieren

12.39

1.04% -0.13

Greenwich Lifesciences Inc (GLSI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	10.54% 2.5372	2.836	2.5029	1.7478	2.2411
Operating Income/Loss	10.54% -2.5372	-2.836	-2.5029	-1.7478	-2.2411
Income/Loss From Continuing Operations Before Tax	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Income/Loss From Continuing Operations After Tax	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Net Income/Loss	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	12.86	-	-	-	-
Diluted Average Shares	12.86	-	12.85	12.85	-
Basic Earnings Per Share	9.52% -0.19	-0.21	-0.19	-0.13	-0.17
Diluted Earnings Per Share	9.52% -0.19	-0.21	-0.19	-0.13	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters